Clinical Trial Update: HOPE Against Cancer Recurrence in HCC [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for HOPE Against Cancer Recurrence in hepatocellular carcinoma; the study is currently recruiting under sponsor Philipp Dutkowski.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Philipp Dutkowski | Conditions: Liver Transplantation, HCC | Phase 4 | Status: RECRUITING